Mark Hendrickson is a senior director based in Washington, D.C. He advises health care coalitions and provides policy counsel and analysis on regulation and legislation. Mark has experience in preparing reports for, drafting regulatory comments to, and testifying before the FDA.
Before joining Leavitt Partners, Mark was the Senior Director of Sciences and Regulatory Affairs at Association for Accessible Medicines (AAM), a trade association for generic pharmaceuticals. He was also an industry negotiator for multiple user fee agreements between the FDA and industry, a role in which he managed several industry working groups focused on pharmaceutical supply chain security and DSCSA implementation.
Mark received his B.A. from Miami University and holds an M.S. in regulatory science from the University of Maryland.